Skip to main content
Drug bottle and Pill

Compare Rituxan vs. Cytoxan

Head-to-head comparisons of medication uses, side effects, warnings, and more.

Key takeaways

Rituxan (rituximab) and cyclophosphamide are both used to treat various cancers, but they work differently and have different uses. Rituxan (rituximab) is a monoclonal antibody that targets specific immune cells called B cells, making it a targeted type of therapy called immunotherapy. It is given as an intravenous infusion and is used for blood cancers like non-Hodgkin lymphoma and chronic lymphocytic leukemia, as well as autoimmune conditions like rheumatoid arthritis. Cyclophosphamide, on the other hand, is a form of chemotherapy. It's an alkylating agent that damages the DNA of cancer cells, leading to cell death. It can be taken orally or intravenously and is used for a broader range of cancers, including lymphomas, leukemias, and breast cancer, as well as nephrotic syndrome in children. Rituxan (rituximab) infusions can take several hours and may cause serious infusion-related reactions, while cyclophosphamide requires you to stay well-hydrated to prevent bladder and kidney problems. Both medications can weaken your immune system, but cyclophosphamide also has a higher risk of causing secondary cancers and fertility issues.

Browse medications

View All

Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.